Quince Therapeutics Inc
NASDAQ:QNCX 4:00:00 PM EDT
Search For a Symbol
Quince Therapeutics Inc Stock, NASDAQ:QNCX
601 Gateway Boulevard, Suite 1250, South San Francisco, California 94080
United States of America
Number of Employees: 21
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.